”Kari Tikkinen's group investigates infliximab and imatinib in the treatment of COVID - Solidarity delivers trustworthy information on COVID drugs”

Press/media: !!Press / Media

!!Description

Interview for Lääkäriportaali

Period9 dec. 2021

Mediabevakning

1

Mediabevakning